ScienceMed®

Simplified Meal Bolus Strategies with Control-IQ+ Automated Insulin Delivery Are Safe and Effective in Adults with Type 2 Diabetes

Endocrinologia

Ensaio clínico randomizadoNível 2 · Nova evidênciaDiabetes technology & therapeutics14 nov 20256 citações

Salvar

Resumo original em inglês

O que aconteceu

To characterize simplified meal bolus strategies in adults with insulin-treated type 2 diabetes using automated insulin delivery (AID).

In the 2IQP study, a 13-week randomized, controlled trial comparing Control-IQ+ AID to continuation of pre-study insulin regimen with continuous glucose monitoring, 201 participants in the AID arm were classified by meal bolus strategy. Glycemic outcomes were compared to baseline.

O que encontraram

68 participants' meal bolus strategies (33.8%) were classified as Carbohydrate Counting, 79 (39.3%) were classified as Preset Carbohydrate Amounts, 27 (13.4%) were classified as Fixed Insulin Doses, and 27 (13.4%) as Other Methods. All bolus strategies were associated with similar, significant improvements in HbA1c from baseline: -0.9% for Carbohydrate Counting (P < 0.001), -1.1% for Preset Carbohydrate Amounts (P < 0.001), -0.8% for Fixed Insulin Doses (P < 0.001), and -0.9% for Other Methods (P = 0.003). Hypoglycemia rates were low at baseline and remained low for all bolus strategies. As participants gained experience with the Control-IQ+ AID system, more participants opted to use a simplified bolus strategy in the second half of the study compared with the first half (63% vs. 52%).

Por que isso importa

Simplified bolus strategies worked well for adults with type 2 diabetes using Control-IQ+ in the 2IQP trial. All bolus strategies led to substantial HbA1c improvements, without safety concerns.

Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.

O estudo original

Simplified Meal Bolus Strategies with Control-IQ+ Automated Insulin Delivery Are Safe and Effective in Adults with Type 2 Diabetes

Carol J Levy, Lauren Kanapka, Sue A Brown, Sheryl Marks, Tamara Spaic, Devin W Steenkamp, Virginia S Lu, Peter Zhao, John W Lum, Roy W. Beck et al.

Descritores MeSH

  • Hypoglycemic Agents
  • Insulin
  • Insulin Infusion Systems
  • Diabetes Mellitus, Type 2
  • Glycated Hemoglobin
  • Humans
  • Hypoglycemia
  • Male
  • Middle Aged
  • Blood Glucose Self-Monitoring

Veja também

Estudos relacionados